Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: A brief communication from the New York Phase II consortium

Gynecologic Oncology

Volumn 100, Issue 1, 2006, Pages 160-165

  Kuo, D Yi Shin ^a,g   Timmins, Patrick ^b   Blank, Stephanie V ^c   Fields, Abbie L ^d   Goldberg, Gary L ^d   Murgo, Anthony ^e   Christos, Paul ^a   Wadler, Scott ^a   Runowicz, Carolyn D ^f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Division of Medical Oncology   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^g NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Advanced disease; Gynecologic sarcoma; Recurrence; Thalidomide

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; THALIDOMIDE; VINCRISTINE;

ABDOMINAL PAIN; ACIDOSIS; ANEMIA; ANGIOGENESIS; ARTICLE; ATAXIA; BACKACHE; BLOOD CLOTTING DISORDER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DROWSINESS; DRUG EFFICACY; DYSPNEA; ELECTROLYTE DISTURBANCE; ERYTHEMA MULTIFORME; FATIGUE; FEMALE; FLUID RETENTION; GASTROINTESTINAL HEMORRHAGE; GYNECOLOGIC CANCER; HEART DISEASE; HUMAN; HYPOTENSION; HYPOXIA; LIVER DISEASE; MEDICAL RECORD; METASTASIS; MIGRAINE; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PARESTHESIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT DISEASE; SARCOMA; SOMNOLENCE; STEVENS JOHNSON SYNDROME; STOMATITIS; SYNCOPE; THROMBOCYTOPENIA; VOMITING;

ADMINISTRATION, ORAL; CARCINOSARCOMA; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; SARCOMA; THALIDOMIDE; TREATMENT OUTCOME;

EID: 29144436646     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.033     Document Type: Article

References (30)

1. S.J. Matthews, and C. McCoy Thalidomide: a review of approved and investigational uses Clin. Ther. 25 2 2003 342 395
2. L. Masiero, W.D. Figg, and E.C. Kohn New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12 Angiogenesis 1 1 1997 23 35
3. M.E. Franks, G.R. Macpherson, and W.D. Figg Thalidomide Lancet 363 2004 1802 1811
4. M.F. McCarty Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis Med. Hypotheses 49 1997 123 131
5. G. Sutton, J.A. Blessing, N. Rosenshein, G. Photopulos, and P.J. DiSaia Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study) Am. J. Obstet. Gynecol. 161 1989 309 312
6. G. Sutton, V.L. Brunetto, L. Kilgore, J.T. Soper, R. McGehee, and G. Olt A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group study Gynecol. Oncol. 79 2000 147 153
7. A. Kurjak, S. Kupesic, H. Shalan, S. Jukic, D. Kosuta, and M. Ilijas Uterine sarcomas: a report of 10 cases studies by transvaginal color and pulsed flow Doppler sonography Gynecol. Oncol. 59 3 1995 342 346
8. H.D. Sinnett, N.P. Rowell, V.R. McCready, and R. Lawrence Demonstration of blood flow patterns in human soft tissues sarcomas using 99m Tc-labelled hexamethylpropyleneamineoxime Br. J. Surg. 77 4 1990 454 457
9. G.A. Omura, F.J. Major, J.A. Blessing, T.V. Sedlacek, J.T. Thigpen, and W.T. Creasman A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advance uterine sarcomas Cancer 52 1983 626 632
10. G.P. Sutton, J.A. Blessing, R.J. Barrett, and R. McGehee Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study Am. J. Obstet. Gynecol. 166 2 1992 556 559
11. J.T. Thigpen, J.A. Blessing, J.W. Orr, and P.J. DiSaia Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group study Cancer Treat. Rep. 70 2 1986 271 274
12. J.T. Thigpen, J.A. Blessing, J. Beecham, H.D. Homesley, and E. Yordan Phase II trial of cisplatin as first line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study J. Clin. Oncol. 9 11 1991 1962 1966
13. G.P. Sutton, J.A. Blessing, and J.H. Malfetano Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study Gynecol. Oncol. 62 2 1996 226 229
14. R.E. Slayton, J.A. Blessing, P.J. DiSaia, and W.A. Christopherson Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group study Cancer Treat. Rep. 71 6 1987 661 662
15. T. Thigpen, J.A. Blessing, E. Yordan, F. Valea, and L. Vacarello Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group (GOG) study Gynecol. Oncol. 63 1 1996 120 122
16. J.L. Currie, J.A. Blessing, H.B. Muss, J. Fowler, M. Berman, and T.W. Burke Combination chemotherapy with hydroxyurea, decarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecology Oncology Group study Gynecol. Oncol. 61 1996 27 30
17. J.T. Thigpen, J.A. Blessing, H.D. Homesley, N. Hacker, and S.L. Curry A phase II trial of piperazinedione in patients with advanced or recurrent uterine sarcoma: a Gynecology Oncology Group study Am. J. Clin. Oncol. 8 1985 350 352
18. G.P. Sutton, J.A. Blessing, H.D. Homesley, and J.H. Malfetano A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum based chemotherapy: a Gynecology Oncology Group study Gynecol. Oncol. 53 1994 24 26
19. H.B. Muss, B.N. Bundy, L. Adcock, and J. Beecham Mitoxantrone in the treatment of advanced uterine sarcoma: a phase II trial of the Gynecologic Oncology Group Am. J. Clin. Oncol. 13 1 1990 32 34
20. R.E. Slayton, J.A. Blessing, K. Look, and B. Anderson A phase II clinical trial of diaziquine (AZQ) in the treatment of patients with recurrent leiomyosarcomas of the uterus: a Gynecologic Oncology Group study Invest. New Drugs 9 1991 207 208
21. R. Asbury, J.A. Blessing, and D. Moore A phase II trial of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus Am. J. Clin. Oncol. 19 4 1996 400 402
22. M.L. Hensley, R. Maki, E. Venkatraman, G. Geller, M. Lovegren, and C. Aghajanian Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial J. Clin. Oncol. 20 2002 2824 2831
23. D.G. Gallup, J.A. Blessing, W. Anderson, and M.A. Morgan Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a Gynecologic Oncology Group study Gynecol. Oncol. 89 2003 48 51
24. R.C. Hastings, J.R. Trautman, C.D. Enna, and R.R. Jacobson Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum Clin. Pharmacol. Ther. 11 1970 481 487
25. G. Kaplan, S. Thomas, D.S. Fierer, K. Mulligan, P.A.J. Haslett, and W.J. Fessel Thalidomide for the treatment of AIDS-associated wasting AIDS Res. Hum. Retroviruses 16 2000 1345 1355
26. D.C. Scoville, and J.C. Reading Open trial of thalidomide in the treatment of rheumatoid arthritis J. Clin. Rheumatol. 5 1999 261 267
27. P. Mehta, A. Kedar, J. Graham-Pole, S. Skoda-Smith, and J.R. Wingard Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature Pediatrics 103 4 1999 e44
28. Ciaravino G, Husain A, Vela AM, Roberts JA, Teng NHH. A study of tolerance and outcome of thalidomide in patients with epithelial ovarian and peritoneal carcinomas. American Society of Clinical Oncology 39th Annual Meeting, Chicago, IL; 2003. Abstract # 1859.
29. N. Abramson, P.K. Stokes, M. Luke, A. Marks, and J. Harris Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomide J. Clin. Oncol. 20 2002 1147 1149
30. S. McMeekin A phase II evaluation of thalidomide in the treatment of recurrent or persistent leiomyosarcoma of the uterus Society of Gynecologic Oncologists Annual meeting, San C.A. Diego 2004 Abstract # 103